ACE2 and COVID-19: We found that secretory and ciliated cells in aged COVID‐19 patients display reduced abundance of angiotensin‐converting enzyme‐2 (ACE2), a key SARS‐CoV‐2 docking receptor (Yan et al., 2020) (Figure 4d).